Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-23
DOI
10.3389/fimmu.2020.01439
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
- (2020) Josef S Smolen et al. ANNALS OF THE RHEUMATIC DISEASES
- Macrophage activation syndrome associated with adult-onset Still’s disease: a multicenter retrospective analysis
- (2020) Ran Wang et al. CLINICAL RHEUMATOLOGY
- Systemic Endothelial Activation Is Associated With Early Acute Respiratory Distress Syndrome in Children With Extrapulmonary Sepsis*
- (2020) Jane E. Whitney et al. CRITICAL CARE MEDICINE
- Correction to: Atherothrombosis Prevention and Treatment with Anti-interleukin-1 Agents
- (2020) Giuseppe Biondi-Zoccai et al. Current Atherosclerosis Reports
- Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
- (2020) Ning Tang et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The response of Milan's Emergency Medical System to the COVID-19 outbreak in Italy
- (2020) Stefano Spina et al. LANCET
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease
- (2020) Peter Richardson et al. LANCET
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
- (2020) Eva Schrezenmeier et al. Nature Reviews Rheumatology
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Connective tissue disease-associated interstitial lung disease
- (2020) R.P. Oliveira et al. Pulmonology
- Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series
- (2020) Achille Aouba et al. ANNALS OF THE RHEUMATIC DISEASES
- To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic
- (2020) Konstantinos Parperis ANNALS OF THE RHEUMATIC DISEASES
- To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
- (2020) Francesca Romana Spinelli et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
- (2020) Sara Monti et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
- (2020) Carina Mihai et al. ANNALS OF THE RHEUMATIC DISEASES
- Response to: Correspondence regarding research letter to the editor by Mathian et al, ‘Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine’’ by Nikpour et al
- (2020) Alexis Mathian et al. ANNALS OF THE RHEUMATIC DISEASES
- COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
- (2020) Serena Colafrancesco et al. AUTOIMMUNITY REVIEWS
- Favorable Anakinra Responses in Severe Covid-19 Patients with Secondary Hemophagocytic Lymphohistiocytosis
- (2020) George Dimopoulos et al. Cell Host & Microbe
- In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- (2020) Xueting Yao et al. CLINICAL INFECTIOUS DISEASES
- Acute hemolysis by hydroxycloroquine was observed in G6PD-deficient patient with severe COVD-19 related lung injury
- (2020) Lucia De Franceschi et al. European Journal of Internal Medicine
- Impact of low dose tocilizumab on mortality rate in patients with COVID-19 related pneumonia
- (2020) Ruggero Capra et al. European Journal of Internal Medicine
- Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
- (2020) Philippe Gautret et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
- (2020) Emanuele Pontali et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Tocilizumab treatment in COVID-19: A single center experience
- (2020) Pan Luo et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- Chloroquine paradox may cause more damage than help fight COVID-19
- (2020) Anuj Sharma MICROBES AND INFECTION
- Adaptations and Lessons in the Province of Bergamo
- (2020) Stefano Fagiuoli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
- (2020) Joshua Geleris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
- (2020) Yan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
- (2020) Jianjun Gao et al. BioScience Trends
- Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
- (2020) Matthieu Mahévas et al. BMJ-British Medical Journal
- Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence
- (2020) Jeanne Lenzer BMJ-British Medical Journal
- COVID-19 cytokine storm: the interplay between inflammation and coagulation
- (2020) Ricardo J Jose et al. Lancet Respiratory Medicine
- Favorable changes of CT findings in a patient with COVID-19 pneumonia after treatment with tocilizumab
- (2020) M. Cellina et al. Diagnostic and Interventional Imaging
- Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro
- (2020) Jia Liu et al. Cell Discovery
- COVID-19: The first documented coronavirus pandemic in history
- (2020) Yen-Chin Liu et al. Biomedical Journal
- HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
- (2020) Francesca Romana Spinelli et al. Science Immunology
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial
- (2020) Pradeesh Sivapalan et al. Trials
- Acute respiratory distress syndrome
- (2019) Michael A. Matthay et al. Nature Reviews Disease Primers
- Hydroxychloroquine reverses the prothrombotic state in a mouse model of antiphospholipid syndrome: Role of reduced inflammation and endothelial dysfunction
- (2019) Sébastien Miranda et al. PLoS One
- Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib – A report of two cases
- (2019) Sarah Wendel et al. JOURNAL OF AUTOIMMUNITY
- Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature
- (2019) Galia Zacay et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
- (2019) Josef S Smolen et al. LANCET
- Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial
- (2019) Piero Ruscitti et al. PLOS MEDICINE
- Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
- (2019) Perner et al. Cells
- Tocilizumab Effects on Coagulation Factor XIII in Patients with Rheumatoid Arthritis
- (2019) Roberta Gualtierotti et al. ADVANCES IN THERAPY
- Tocilizumab therapy in rheumatoid arthritis with interstitial lung disease: a multicenter retrospective study
- (2019) Andreina Manfredi et al. INTERNAL MEDICINE JOURNAL
- Lysosomes as dynamic regulators of cell and organismal homeostasis
- (2019) Andrea Ballabio et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Regulation of Clathrin-Mediated Endocytosis
- (2018) Marcel Mettlen et al. Annual Review of Biochemistry
- Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps
- (2018) Brian A. Boone et al. BMC CANCER
- Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
- (2018) Janette Bester et al. CYTOKINE
- Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
- (2018) Ian C. Scott et al. DRUG SAFETY
- Safety and efficacy of upadacitinib in patients with active rheumatoid arthritis refractory to biologic disease-modifying anti-rheumatic drugs (SELECT-BEYOND): a double-blind, randomised controlled phase 3 trial
- (2018) Mark C Genovese et al. LANCET
- Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort
- (2018) F R Spinelli et al. LUPUS
- Interleukin 1 receptor antagonist (IL1RA ) gene polymorphism and levels associated with adverse outcome in severe community-acquired pneumonia in children: A hospital-based study in India
- (2018) Shally Awasthi et al. PEDIATRIC PULMONOLOGY
- Update on Cardiovascular Disease Risk in Patients with Rheumatic Diseases
- (2018) Rachel H. Mackey et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- Autophagy induces protein carbamylation in fibroblast-like synoviocytes from patients with rheumatoid arthritis
- (2018) Valeria Manganelli et al. RHEUMATOLOGY
- Systemic inflammatory response syndromes in the era of interventional cardiology
- (2018) Riccardo Gorla et al. VASCULAR PHARMACOLOGY
- Examination of Hydroxychloroquine Use and Hemolytic Anemia in G6PDH-Deficient Patients
- (2018) Samya Mohammad et al. ARTHRITIS CARE & RESEARCH
- Treatment of Dilated Cardiomyopathy With Interleukin-1 Inhibition
- (2018) Giacomo De Luca et al. ANNALS OF INTERNAL MEDICINE
- Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option
- (2018) Srinivasa Reddy Bonam et al. JOURNAL OF AUTOIMMUNITY
- Interleukin-1 Receptor Antagonist Is Associated With Pediatric Acute Respiratory Distress Syndrome and Worse Outcomes in Children With Acute Respiratory Failure
- (2018) Mary K. Dahmer et al. Pediatric Critical Care Medicine
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- OUP accepted manuscript
- (2018) RHEUMATOLOGY
- Tocilizumab and the risk for cardiovascular disease: a direct comparison among biologic disease-modifying antirheumatic drugs for rheumatoid arthritis patients
- (2018) Fenglong Xie et al. ARTHRITIS CARE & RESEARCH
- Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy
- (2018) Tianxi Cai et al. JAMA Cardiology
- HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome
- (2018) Cristina Belizna et al. AUTOIMMUNITY REVIEWS
- Chloroquine attenuates TLR3-mediated plasminogen activator inhibitor-1 expression in cultured human glomerular endothelial cells
- (2018) Tomomi Aizawa et al. Clinical and Experimental Nephrology
- Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy
- (2018) Hajime Yoshifuji Modern Rheumatology
- Hydroxychloroquine partially prevents endothelial dysfunction induced by anti-beta-2-GPI antibodies in an in vivo mouse model of antiphospholipid syndrome
- (2018) Geoffrey Urbanski et al. PLoS One
- The Inter-Relationship of Platelets with Interleukin-1β-Mediated Inflammation in Humans
- (2018) Rahajeng Tunjungputri et al. THROMBOSIS AND HAEMOSTASIS
- Comparative risk of venous thromboembolism with tofacitinib versus tumor necrosis factor inhibitors: A cohort study of rheumatoid arthritis patients
- (2018) Rishi J. Desai et al. Arthritis & Rheumatology
- Anakinra Therapy for Non-cancer Inflammatory Diseases
- (2018) Giulio Cavalli et al. Frontiers in Pharmacology
- Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent
- (2017) C. J. Reddel et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Venous thromboembolism: thrombosis, inflammation, and immunothrombosis for clinicians
- (2017) Eduardo Vazquez-Garza et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
- (2017) Roy Fleischmann et al. LANCET
- Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease
- (2017) D Erkan et al. LUPUS
- JAK inhibition as a therapeutic strategy for immune and inflammatory diseases
- (2017) Daniella M. Schwartz et al. NATURE REVIEWS DRUG DISCOVERY
- The emerging safety profile of JAK inhibitors in rheumatic disease
- (2017) Kevin L. Winthrop Nature Reviews Rheumatology
- Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis
- (2017) Peter C. Taylor et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies
- (2017) Karen Schreiber et al. RHEUMATOLOGY
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Coagulation and sepsis
- (2017) Marcel Levi et al. THROMBOSIS RESEARCH
- IL-6 ameliorates acute lung injury in influenza virus infection
- (2017) Mei-Lin Yang et al. Scientific Reports
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still’s Disease: A Multicentre Retrospective Observational Study
- (2017) Serena Colafrancesco et al. Frontiers in Pharmacology
- IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
- (2017) Concepción Peiró et al. Frontiers in Pharmacology
- Interleukin-1 Receptor Blockade Rescues Myocarditis-Associated End-Stage Heart Failure
- (2017) Giulio Cavalli et al. Frontiers in Immunology
- Pulmonary arterial hypertension and acute respiratory distress syndrome in a patient with adult-onset stills disease
- (2017) Grant H. Lowther et al. Pulmonary Circulation
- The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis
- (2016) Bethany T. Samuelson et al. BLOOD COAGULATION & FIBRINOLYSIS
- Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome
- (2016) Bita Shakoory et al. CRITICAL CARE MEDICINE
- Clinical Progression and Cytokine Profiles of Middle East Respiratory Syndrome Coronavirus Infection
- (2016) Eu Suk Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Macrophage activation syndrome complicating adult onset Still’s disease: A single center case series and comparison with literature
- (2016) Aleksander Lenert et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor
- (2016) Christina Charles-Schoeman et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Family-wide Structural Analysis of Human Numb-Associated Protein Kinases
- (2016) Fiona J. Sorrell et al. STRUCTURE
- JAK-2 V617F mutation increases heparanase procoagulant activity
- (2016) Inna Kogan et al. THROMBOSIS AND HAEMOSTASIS
- Adult onset Still's disease accompanied by acute respiratory distress syndrome: A case report
- (2016) Xiao-Tu Xi et al. Experimental and Therapeutic Medicine
- NLRP3 Inflammasome Expression and Activation in Human Atherosclerosis
- (2016) Geena Paramel Varghese et al. Journal of the American Heart Association
- The JAK-STAT Pathway: Impact on Human Disease and Therapeutic Intervention
- (2015) John J. O'Shea et al. Annual Review of Medicine
- Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
- (2015) Sarah Skeoch et al. Nature Reviews Rheumatology
- Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection
- (2014) Yaseen M. Arabi et al. ANNALS OF INTERNAL MEDICINE
- AB0037 Evaluation of the binding kinetics and functional bioassay activity of sarilumab and tocilizumab to the human il-6 receptor (il-6r) alpha
- (2014) A. Rafique et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammation and Atherosclerosis
- (2014) Joshua Hartman et al. Cardiology in Review
- Critical Role for the NLRP3 Inflammasome during Acute Lung Injury
- (2014) J. J. Grailer et al. JOURNAL OF IMMUNOLOGY
- Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study
- (2014) C. A. Kelly et al. RHEUMATOLOGY
- Role of alpha-synuclein in autophagy modulation of primary human T lymphocytes
- (2014) T Colasanti et al. Cell Death & Disease
- Pleiotropic Effects of Interleukin-6 in a “Two-Hit” Murine Model of Acute Respiratory Distress Syndrome
- (2014) Julia L. Goldman et al. Pulmonary Circulation
- Effects of Interleukin-1 Blockade With Anakinra on Adverse Cardiac Remodeling and Heart Failure After Acute Myocardial Infarction [from the Virginia Commonwealth University-Anakinra Remodeling Trial (2) (VCU-ART2) Pilot Study]
- (2013) Antonio Abbate et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis
- (2013) Aart C. Strang et al. ATHEROSCLEROSIS
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome
- (2013) Cristina Rosário et al. BMC Medicine
- Activation of NLRP3 Inflammasome in Alveolar Macrophages Contributes to Mechanical Stretch-Induced Lung Inflammation and Injury
- (2013) J. Wu et al. JOURNAL OF IMMUNOLOGY
- The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus
- (2013) P. S. Akhavan et al. JOURNAL OF RHEUMATOLOGY
- Novel small molecule therapeutics in rheumatoid arthritis
- (2013) V. Kelly et al. RHEUMATOLOGY
- Efficacy of tocilizumab for interstitial lung disease in an undifferentiated autoinflammatory disorder partially responsive to anakinra
- (2013) S. M. Keidel et al. RHEUMATOLOGY
- Proteinase-activated receptors in fibroproliferative lung disease
- (2013) Ricardo J José et al. THORAX
- The inflammasome in lung diseases
- (2012) Gimena dos Santos et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Ventilator-induced Lung Injury Is Mediated by the NLRP3 Inflammasome
- (2012) Maria T. Kuipers et al. ANESTHESIOLOGY
- T lymphocytes from patients with systemic lupus erythematosus are resistant to induction of autophagy
- (2012) Cristiano Alessandri et al. FASEB JOURNAL
- Role of IL-6 in Asthma and Other Inflammatory Pulmonary Diseases
- (2012) Mercedes Rincon et al. International Journal of Biological Sciences
- Essential role of IL-6 in protection against H1N1 influenza virus by promoting neutrophil survival in the lung
- (2012) O Dienz et al. Mucosal Immunology
- Sensing and reacting to microbes through the inflammasomes
- (2012) Luigi Franchi et al. NATURE IMMUNOLOGY
- Lung strain and biological response in mechanically ventilated patients
- (2011) Adrián González-López et al. INTENSIVE CARE MEDICINE
- Autophagy in immunity and inflammation
- (2011) Beth Levine et al. NATURE
- Pregnancy and reproduction in autoimmune rheumatic diseases
- (2010) M. Ostensen et al. RHEUMATOLOGY
- Use of Hydroxychloroquine to Prevent Thrombosis in Systemic Lupus Erythematosus and in Antiphospholipid Antibody–Positive Patients
- (2010) Michelle Petri Current Rheumatology Reports
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-6 Is Crucial for Recall of Influenza-Specific Memory CD4+ T Cells
- (2008) Maria Paula Longhi et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search